Schizophrenia Clinical Trials

Available for qualified participants

Schizophrenia Clinical Trials

Available for qualified participants

Schizophrenia Clinical Research Trials

Schizophrenia is a severe and chronic mental illness which impacts approximately 1% of the population. A person with schizophrenia experiences changes in the way he or she thinks, feels and behaves. 

People with schizophrenia may have a variety of symptoms, ranging from believing in ideas which are obviously not true, or feeling paranoid and suspicious; as if everyone is out to get them. They may become isolated and avoid contact with others. They may hear voices or see visions that they believe are real. Sometimes, they will talk back to the voices or the visions as if they were real. 

They may become less able to complete their daily activities such as showering, washing clothes, and eating properly. They may also lack energy and motivation to take part in activities they used to enjoy. 

People with schizophrenia may have problems making good decisions, and they may have problems with their memory. 

Schizophrenia treatment research is designed to find new ways to prevent, detect, or treat the disease. At CBHHealth, we focus on researching new schizophrenia treatments that can help reduce the symptoms and the suffering associated with this illness. 

If you, or someone you know, lives with schizophrenia, please contact us and let’s explore how our upcoming clinical trials might be of assistance in the management and treatment of schizophrenia symptoms. 

 
We have helped tens of thousands of patients in similar studies.
Space in this study is limited. To be considered, please fill out the form or call 301-251-4702.

STUDY DETAILS

No cost studies are currently available for qualified participants.

fas|fa-file-alt|

No health insurance required

fas|fa-money-check-alt|

Compensation for time and travel TBD

fas|fa-stopwatch|

Lives with schizophrenia

fas|fa-user|

Male / Female

fas|fa-birthday-cake|

18-65 years old

mt|location_on|

9318 Gaither Road, Ste 265
Gaithersburg, MD 20877

State of the Art Facilities

CBH is Maryland’s premier clinical research organization. For a decade, we’ve helped improve the quality of life for everyone by researching new medications and treatments. Our state-of-the-art facilities are held to the highest standards of cleanliness and quality.

Board Certified Physicians

Your safety is our greatest concern. Every procedure at CBH is overseen by expert medical staff and performed by some of the most well-respected board-certified physicians in the industry, each with many years of experience in their respective specialties.

FDA Approved Procedures

Rest assured, you are not signing up for treatment with “experimental” methods. CBH only uses FDA approved methods as if you were at any other hospital or clinic. Our research is focused on the medication associated with those methods.

Frequently asked questions

What is a CenExel Center of Excellence?

CenExel Centers of Excellence provide unparalleled medical and scientific support in the design and execution of clinical trials. Their attention to detail assures quality, reliable results and has helped CenExel to consistently achieve and exceed patient recruitment goals. They have conducted thousands of studies, the variety and complexity of which have resulted in a great depth of experience and insight for the principal investigators and research staff in each facility. CenExel Centers of Excellence deliver the engagement, expertise, and results to ensure that clients achieve their clinical research goals.

How do clinical trials work?

The study procedures and process will vary depending on the type of clinical trial you participate in. Before you begin a study, the process and all procedures for that study will be explained to you. Throughout the study, the Study Coordinator and the Principal Investigator will assist you and can answer any questions you have. They will check your health at the beginning of the trial, give you specific instructions for participating in the trial, monitor you carefully during the trial, and stay in touch with you after the study.

Some clinical trials involve more tests and doctor visits than you would normally have for your illness or condition. Your participation will be most successful if you carefully follow all instructions you are given and stay in contact with the research staff.

How safe are clinical studies?

There are many safeguards in place that all companies must follow when conducting clinical trials.

The Food and Drug Administration (FDA) is the regulatory agency that oversees all clinical research conducted in the United States. It is their responsible to protect the rights and as much as possible, the welfare of subjects participating in clinical trials. They ensure that data collected from clinical trials is of the highest quality and they are the agency that determines whether a new treatment should be sold in the US. Several organizations and individuals are governed by FDA regulations including clinical investigators, sponsors (the companies developing the treatments), Contract Research Organizations (companies that help conduct the studies), and Institutional Review Boards (groups that are responsible for ensuring the safety and welfare of study participants).

Good Clinical Practice (GCP) guidelines are another safeguard implemented to protect the safety of subjects. These guidelines encompass federal regulations and industry-accepted standards that govern clinical trials on humans. These regulations and standards apply to the conduct of the studies, record keeping, informed consent of subjects, collection of scientific data, and submission of information needed for the FDA to determine whether a new treatment should or should not be sold in the US. All companies must follow these guidelines when conducting clinical research.

An Institutional Review Board (IRB) is a committee that is formally tasked by an institution to review, approve, and monitor research involving human subjects. IRBs ensure that the risks to subjects are minimized; that subjects are adequately informed about the trial and the implications it will have on their treatment; that study protocols are modified, when necessary, to ensure safety; that risks are reasonable in relation to the anticipated benefits and the importance of the knowledge to be gained; that subject selection is equitable and that no classes of patients are discriminated against; that informed consent is obtained; that there is a provision for safety monitoring in the research plan; and that here are adequate provisions for the privacy and confidentiality for subjects and the data collected.

Translate »